the market?
Vanda Pharmaceuticals, Inc.
NASDAQ: VNDA
7.12
0.15
(2.15%)
| Today's Open | $6.86 |
|---|---|
| Previous Close | $6.97 |
| Daily Range | $6.36 - $7.26 |
| 52-Week Range | $2.92 - $7.53 |
| Market Cap | $201.8M |
| P/E Ratio | -8.20 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 492,280 |
| Average Daily Volume | 460,295 |
| Current FY EPS | -$0.94 |
How do you think VNDA
will perform against the market?
Top VNDA Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
August 4, 2011
If you're looking around for falling knives to catch, may I recommend Vanda? The stock can never get any liftoff because royalties from their single product Fanapt have plateaued under 1M/quarter, and … More
hlacheen (< 20)
Submitted
February 14, 2007
Utter garbage.... like most pharmaceutical companies with huge losses and horrible balance sheets.
News & Commentary
Vanda Drug Fails in Depression Study
Tasimelteon remains on track to as a potential treatment for non-24-hour sleep-wake disorder.You Should Have Seen These Biotech Failures Coming
Microcap biotechs are a value for a reason.The Big Bet on Cell Therapeutics
Will the FDA change its mind about pixantrone?Sector
Healthcare
Industry
Drugs
Vanda Pharmaceuticals, Inc. (VNDA) Description
A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website: http://www.vandapharmaceuticals.com/
